“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit Follow Mineralys on LinkedIn, Twitter and Bluesky”

Mineralys is a fully remote company.

Director Statistical Programmer

The Director Statistical Programing (SP) reports to the SVP, Biometrics and is accountable for the production of SDTM and ADAM datasets and Tables, Listings, and Graph output (TFLs) for clinical studies. They will collaborate with partner functions in the Clinical Development Department (e.G. Clinical Operations, Clinical...